subject: How to Reduce Niaspan Side Effects [print this page] Because clinical studies are conducted under widely various develops, adverse chemical reaction rates observed in the clinical reports of a drug cannot be directly compared to grades in the impersonal studies of another drug and may not muse the ranges found in practice.
Clinical Studies Experience
In the placebo-controlled verifiable trials database of 432 patients (age range 21-73 years, 31% women, 59% Caucasians, 5% Inkinesses, 5% Hispanics, 2% Asians) with a average treatment length of 13 weeks, 13% of patient roles on Niaspan side effects and 5% of patient roles on placebo ceased due to adverse responses. The most base adverse responses in the group of patient roles treated with side effects of Niaspan that led to discourse discontinuation and happened at a rate heavier than placebo were flushing (6% vs. 2%), rash (1% vs. 5%), diarrhea (3% vs. 5%), nausea (2% vs. 1%), and honking (1% vs. 2%). The most usually reported adverse responses (incidence >3% and greater than placebo) in the Niaspan controlled clinical trial database of 401 affected roles were blushing, looseness of the bowels, nausea, regurgitation, increased coughing and pruritus.
In the placebo-controlled neutral trials, purging episodes (i.e., fondness, redness, itching and/or tingling) were the almost low treatment-emergent disapproving chemical reactions (reported by as many as 83% of patients) for Niaspan side effects. Spontaneous papers hint that flushing may also be companied by symptoms of dizziness, tachycardia, shakings, shortness of breather, sweating, main sensation/skin burning virtuoso, chills, and/or oedema, which in rare events may lead to faint. In pivotal studies, 6% (14/241) side effects of Niaspan patients stopped due to evening. In comparisons of immediate-release (IR) niacin side effects and Niaspan, although the symmetry of affected roles who flushed was like, fewer flushing episodes were reported by affected roles who received side effects of Niaspan. Tracing 4 weeks of criminal maintenance therapy at daily panes of 1500 milligram, the relative incidence of scouring over the 5-week time period averaged out 8.6 events per patient for IR side effects of niacin versus 1.3 coming Niaspan.
The following additional adverse chemical reactions have been identified during post-approval function of Niaspan:
Hypersensitivity chemical reactions, including anaphylaxis, angioedema, urticaria, flushing, dyspnoea, tongue edema, larynx oedema, face edema, peripheral oedema, laryngismus, and vesiculobullous rash; maculopapular efflorescence; dry skin; tachycardia; quivers; atrial fibrillation; old cardiac arrhythmias; syncope; hypotension
